Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neutralizing Antibodies in COVID-19 Serum from Tatarstan, Russia.
Hamza S, Martynova E, Garanina E, Shakirova V, Bilalova A, Moiseeva S, Khaertynova I, Ohlopkova O, Blatt N, Markelova M, Khaiboullina S. Hamza S, et al. Among authors: khaertynova i. Int J Mol Sci. 2023 Jun 15;24(12):10181. doi: 10.3390/ijms241210181. Int J Mol Sci. 2023. PMID: 37373331 Free PMC article.
Long Term Immune Response Produced by the SputnikV Vaccine.
Martynova E, Hamza S, Garanina EE, Kabwe E, Markelova M, Shakirova V, Khaertynova IM, Kaushal N, Baranwal M, Rizvanov AA, Urbanowicz RA, Khaiboullina SF. Martynova E, et al. Int J Mol Sci. 2021 Oct 18;22(20):11211. doi: 10.3390/ijms222011211. Int J Mol Sci. 2021. PMID: 34681885 Free PMC article.
Characterization of the Puumala orthohantavirus Strains in the Northwestern Region of the Republic of Tatarstan in Relation to the Clinical Manifestations in Hemorrhagic Fever With Renal Syndrome Patients.
Davidyuk YN, Kabwe E, Shakirova VG, Martynova EV, Ismagilova RK, Khaertynova IM, Khaiboullina SF, Rizvanov AA, Morzunov SP. Davidyuk YN, et al. Front Pharmacol. 2019 Sep 5;10:970. doi: 10.3389/fphar.2019.00970. eCollection 2019. Front Pharmacol. 2019. PMID: 31543819 Free PMC article.
Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients.
Garanina E, Hamza S, Stott-Marshall RJ, Martynova E, Markelova M, Davidyuk Y, Shakirova V, Kaushal N, Baranwal M, Khaertynova IM, Rizvanov A, Foster TL, Khaiboullina S. Garanina E, et al. Among authors: khaertynova im. Front Microbiol. 2022 Apr 18;13:842232. doi: 10.3389/fmicb.2022.842232. eCollection 2022. Front Microbiol. 2022. PMID: 35509311 Free PMC article.
Δccr5 Genotype Is Associated with Mild Form of Nephropathia Epidemica.
Kletenkov K, Martynova E, Davidyuk Y, Kabwe E, Shamsutdinov A, Garanina E, Shakirova V, Khaertynova I, Anokhin V, Tarlinton R, Rizvanov A, Khaiboullina S, Morzunov S. Kletenkov K, et al. Among authors: khaertynova i. Viruses. 2019 Jul 23;11(7):675. doi: 10.3390/v11070675. Viruses. 2019. PMID: 31340562 Free PMC article.
Urinary Clusterin Is Upregulated in Nephropathia Epidemica.
Martynova EV, Maksudova AN, Shakirova VG, Abdulkhakov SR, Khaertynova IM, Anokhin VA, Ivanova VV, Abiola IM, Garanina EE, Tazetdinova LG, Valiullina AH, Khaiboullina SF. Martynova EV, et al. Dis Markers. 2018 Feb 26;2018:8658507. doi: 10.1155/2018/8658507. eCollection 2018. Dis Markers. 2018. PMID: 29682100 Free PMC article.
Epidemiological dynamics of nephropathia epidemica in the Republic of Tatarstan, Russia, during the period of 1997-2013.
Khismatullina NA, Karimov MM, Khaertynov KS, Shuralev EA, Morzunov SP, Khaertynova IM, Ivanov AA, Milova IV, Khakimzyanova MB, Sayfullina GSh, Gaynullin AA, Ivanov AV, Rizvanov AA, Khaiboullina SF. Khismatullina NA, et al. Among authors: khaertynova im. Epidemiol Infect. 2016 Feb;144(3):618-26. doi: 10.1017/S0950268815001454. Epub 2015 Jul 10. Epidemiol Infect. 2016. PMID: 26160776
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.
Jayk Bernal A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, Delos Reyes V, Martín-Quirós A, Caraco Y, Williams-Diaz A, Brown ML, Du J, Pedley A, Assaid C, Strizki J, Grobler JA, Shamsuddin HH, Tipping R, Wan H, Paschke A, Butterton JR, Johnson MG, De Anda C; MOVe-OUT Study Group. Jayk Bernal A, et al. N Engl J Med. 2022 Feb 10;386(6):509-520. doi: 10.1056/NEJMoa2116044. Epub 2021 Dec 16. N Engl J Med. 2022. PMID: 34914868 Free PMC article. Clinical Trial.
Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial.
Johnson MG, Strizki JM, Brown ML, Wan H, Shamsuddin HH, Ramgopal M, Florescu DF, Delobel P, Khaertynova I, Flores JF, Fouche LF, Chang SC, Williams-Diaz A, Du J, Grobler JA, Paschke A, De Anda C. Johnson MG, et al. Among authors: khaertynova i. Infection. 2023 Oct;51(5):1273-1284. doi: 10.1007/s15010-022-01959-9. Epub 2023 Jan 17. Infection. 2023. PMID: 36648627 Free PMC article. Clinical Trial.
24 results